GoodRx Holdings, Inc. Net Income Loss

• GoodRx Holdings, Inc. showed an increase of +85.7% in Net Income Loss from 2024 to 2025.
• This data is from GoodRx Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), GoodRx Holdings, Inc.'s Net Income Loss has declined by 30.5%.
• Historical annual values: Fiscal year 2025: $30.44 million | Fiscal year 2024: $16.39 million | Fiscal year 2023: -$8.87 million | Fiscal year 2022: -$32.83 million | Fiscal year 2021: -$25.25 million | Fiscal year 2020: -$293.62 million | Fiscal year 2019: $66.05 million | Fiscal year 2018: $43.79 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026